Lubin Investment · Analyze · Screener · Compare

Best Drug Manufacturers General stocks by quality

Of the 60 stocks listed here, none currently reaches the maximum quality score. The median valuation of the group comes out at 23.9 times its free cash flow.

The Drug Manufacturers General stocks with the highest scores from our fundamental analysis, ranked from best to worst quality, with their valuation (P/FCF). Click a stock for its full analysis.

#StockQuality scoreP/FCF
1Recordati Industria Chimica e Farmaceutica S.p.A. (REC.MI)9/1021.8x
2Pfizer Limited (PFIZER.NS)9/1019.7x
3Orion Oyj (ORNBV.HE)9/1052.3x
4Novartis AG (NOVN.SW)9/1015.8x
5Otsuka Holdings Co., Ltd. (4578.T)9/1021.4x
6Sanofi India Limited (SANOFI.NS)8/1017.2x
7Roche Holding AG (ROP.SW)8/1022.4x
8Roche Holding AG (RO.SW)8/1022.6x
9NGL Fine-Chem Limited (NGLFINE.NS)8/10n.d.
10Eli Lilly and Co (LLY)8/1055.7x
11GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS)8/1059.6x
12AstraZeneca PLC (AZN.ST)8/10294.7x
13AstraZeneca PLC (AZN.L)8/1029.2x
14AstraZeneca PLC (AZN)8/1024.3x
15Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS)8/10n.d.
16Virbac SA (VIRP.PA)7/1024.1x
17Senores Pharmaceuticals Limited (SENORES.NS)7/10n.d.
18Sanofi Consumer Healthcare India Limited (SANOFICONR.NS)7/1055.4x
19Novartis AG (NVS)7/1013.8x
20Novo Nordisk A/S (NVO)7/1040.8x
21Marksans Pharma Limited (MARKSANS.NS)7/1045.6x
22Haw Par Corporation Limited (H02.SI)7/1054.4x
23Grifols, S.A. (GRF.MC)7/1011.1x
24CORONA Remedies Limited (CORONA.NS)7/10231.4x
25Bristol-Myers Squibb Co (BMY)7/1011.5x
26Santen Pharmaceutical Co., Ltd. (4536.T)7/108.7x
27Chugai Pharmaceutical Co., Ltd. (4519.T)7/1041.1x
28Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ)7/1032.9x
29Tong Ren Tang Technologies Co. Ltd. (1666.HK)7/102.3x
30Rubicon Research Limited (RUBICON.NS)6/9n.d.
31Sanofi SA (SNY)6/108.8x
32SMS Pharmaceuticals Limited (SMSPHARMA.NS)6/10n.d.
33Sanofi (SAN.PA)6/1013.1x
34Sai Parenteral's Limited (SAIPARENT.NS)6/1070.8x
35Novo Nordisk A/S (NOVO-B.CO)6/1046.8x
36Merck & Co Inc (MRK)6/1023.7x
37PT Kalbe Farma Tbk. (KLBF.JK)6/1014.7x
38Johnson & Johnson (JNJ)6/1028.9x
39GSK plc (GSK.L)6/1016.0x
40Grifols SA (GRFS)6/109.4x
41Gilead Sciences, Inc (GILD)6/1013.8x
42Amgen Inc (AMGN)6/1027.0x
43AbbVie Inc (ABBV)6/1022.7x
44Alebund Pharmaceuticals (Jiangsu) Limited (9637.HK)6/10n.d.
45Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (900904.SS)6/1017.7x
46IMPACT Therapeutics, Inc (7630.HK)6/10n.d.
47Jiangxi Institute of Biological Products Inc. (6915.HK)6/10133.2x
48GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS)6/1035.8x
49Aurora Optoelectronics Co.,Ltd. (600666.SS)6/10n.d.
50Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SS)6/1054.0x
51Daiichi Sankyo Company, Limited (4568.T)6/10n.d.
52Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ)6/1073.0x
53Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ)6/10n.d.
54Yifan Pharmaceutical Co., Ltd. (002019.SZ)6/10n.d.
55Myung In Pharmaceutical LTD. (317450.KS)5/913.6x
56TTK Healthcare Limited (TTKHLTCARE.NS)5/10n.d.
57Nasus Pharma Ltd (NSRX)5/10n.d.
58MIRA Pharmaceuticals Inc (MIRA)5/10n.d.
59Medicus Pharma Ltd (MDCX)5/10n.d.
60Kopran Limited (KOPRAN.NS)5/10n.d.

Our quality score judges how solid a business is across 10 objective financial criteria (profitability, free cash flow growth, share buybacks, debt, return on capital). The P/FCF (price to free cash flow) shows whether the stock is cheap or expensive. Full method: our methodology.

To place these multiples against sector averages, the reference public sector data is Aswath Damodaran's (NYU Stern).

Explore the full screener